Fractal-based autonomous partial discharge pattern recognition method for MV motors

On-line partial discharge (PD) monitoring is being increasingly adopted to improve the asset management and maintenance of medium-voltage (MV) motors. This study presents a novel method for autonomous analysis and classification of motor PD patterns in situations where a phase-reference voltage waveform is not available. The main contributions include a polar PD (PPD) pattern and a fractal theory-based autonomous PD recognition method. PPD pattern that is applied to convert the traditional phase-resolved PD pattern into a circular form addresses the lack of phase information in on-line PD monitoring system. The fractal theory is then presented in detail to address the task of discrimination of 6 kinds of single source and 15 kinds of multi-source PD patterns related to motors, as outlined in IEC 60034. The classification of known and unknown defects is calculated by a method known as centre score. Validation of the proposed method is demonstrated using data from laboratory experiments on three typical PD geometries. This study also discusses the application of the proposed techniques with 24 sets of on-site PD measurement data from 4 motors in 2 nuclear power stations. The results show that the proposed method performs effectively in recognising not only the single-source PD but also multi-source PDs

Cytotoxic activity of the sub-fraction 2125 from Vernonia scorpioides against Sarcoma 180 tumor cells in mice

The effect of the selected sub-fraction SF-2125 of the Vernonia scorpioides leaf extract on Sarcoma 180 (S180) ascitic tumor-bearing mice was investigated. The animals were treated with SF-2125 at a concentration of 5 mg/kg, administered intraperitoneally and intravenous during the development of the tumor. Treatment with SF-2125 5 mg/kg i.p. increased the lifespan of the animals, maintained their body and the ascitic tumor showed no development. Intravenous treatment did not reduce the tumor volume

U-SPECT-BioFluo: an integrated radionuclide, bioluminescence, and fluorescence imaging platform

Background: In vivo bioluminescence, fluorescence, and single-photon emission computed tomography (SPECT) imaging provide complementary information about biological processes. However, to date these signatures are evaluated separately on individual preclinical systems. In this paper, we introduce a fully integrated bioluminescence-fluorescence-SPECT platform. Next to an optimization in logistics and image fusion, this integration can help improve understanding of the optical imaging (OI) results. Methods: An OI module was developed for a preclinical SPECT system (U-SPECT, MILabs, Utrecht, the Netherlands). The applicability of the module for bioluminescence and fluorescence imaging was evaluated in both a phantom and in an in vivo setting using mice implanted with a 4 T1-luc + tumor. A combination of a fluorescent dye and radioactive moiety was used to directly relate the optical images of the module to the SPECT findings. Bioluminescence imaging (BLI) was compared to the localization of the fluorescence signal in the tumors. Results: Both the phantom and in vivo mouse studies showed that superficial fluorescence signals could be imaged accurately. The SPECT and bioluminescence images could be used to place the fluorescence findings in perspective, e.g. by showing tracer accumulation in non-target organs such as the liver and kidneys (SPECT) and giving a semi-quantitative read-out for tumor spread (bioluminescence). Conclusions: We developed a fully integrated multimodal platform that provides complementary registered imaging of bioluminescent, fluorescent, and SPECT signatures in a single scanning session with a single dose of anesthesia. In our view, integration of these modalities helps to improve data interpretation of optical findings in relation to radionuclide images

Ensuring HLA-matched platelet support requires an ethnic diverse donor population

BACKGROUND: Patients refractory for platelet transfusions benefit from human leukocyte antigen (HLA)-matched platelet transfusions. Differences in ethnic background of patients and donors could hamper the availability of sufficient numbers of HLA-matched donors for all patients. We evaluated our HLA-matched donor program and explored the role of ethnic background of patients related to the number of available donors. METHODS: We performed a cohort study among consecutive patients who received HLA-matched platelet concentrates in the Netherlands between 1994 and 2017. The number of available matched donors was determined per patient. Haplotypes were constructed from genotypes with computer software (PyPop). Based on haplotypes, HaploStats, an algorithm from the National Marrow Donor Program, was used to assess the most likely ethnic background for patients with 5 or fewer and 30 or more donors. RESULTS: HLA typing was available for 19,478 donors in September 2017. A total of 1206 patients received 12,350 HLA-matched transfusions. A median of 83 (interquartile range, 18-266) donors were available per patient. For 95 (10.3%) patients, 5 or fewer donors were available. These patients were more likely to have an African American background, whereas patients with 30 or more donors were more often from Caucasian origin, compared with Caucasian origin for patients with 30 donors. CONCLUSION: Adequate transfusion support could be guaranteed for most but not all refractory patients. More non-Caucasian donors are required to ensure the availability of HLA-matched donors for all patients in the Netherlands

Tests of the Equivalence Principle with Neutral Kaons

We test the Principle of Equivalence for particles and antiparticles, using CPLEAR data on tagged K0 and K0bar decays into pi^+ pi^-. For the first time, we search for possible annual, monthly and diurnal modulations of the observables |eta_{+-}| and phi_{+-}, that could be correlated with variations in astrophysical potentials. Within the accuracy of CPLEAR, the measured values of |eta_{+-}| and phi_{+-} are found not to be correlated with changes of the gravitational potential. We analyze data assuming effective scalar, vector and tensor interactions, and we conclude that the Principle of Equivalence between particles and antiparticles holds to a level of 6.5, 4.3 and 1.8 x 10^{-9}, respectively, for scalar, vector and tensor potentials originating from the Sun with a range much greater than the distance Earth-Sun. We also study energy-dependent effects that might arise from vector or tensor interactions. Finally, we compile upper limits on the gravitational coupling difference between K0 and K0bar as a function of the scalar, vector and tensor interaction range.Comment: 15 pages latex 2e, five figures, one style file (cernart.csl) incorporate

Outflows of very ionized gas in the center of Seyfert galaxies: kinematics and physical conditions

Mid-resolution spectra are used to deduce the size and kinematics of the coronal gas in a sample of Seyfert galaxies by means of observations of the [FeXI], [FeX], [FeVII], [SiVI] and [SiVII] lines. These coronal lines (CL) extend from the unresolved nucleus up to a few tens to a few hundreds of parsecs. The region of the highest ionized ions studied, [FeXI] and [FeX], is the least spatially extended, and concentrates at the center; intermediate ionization lines extend from the nucleus up to a few tens to a few hundred parsecs; lower [OIII]-like ions are known to extendin the kpc range. All together indicates a stratification in the ionized gas, usually interpreted in terms of nuclear photoionization as the driving ionization mechanism. However, CL profiles show various peculiarities: they are broader by a factor of two than lower ionization lines, the broadening being in terms of asymmetric blue wings, and their centroid position at the nucleus is blueshifted by a few hundreds of km/s. Moreover, in NGC1386 and NGC1068, a double peak [FeVII] line is detected in the nuclear and extended coronal region, this being the first report in of such type of profile in CL in active galactic nuclei. If interpreted as outflow signatures, the total broadening of the lines at zero intensity levels implies gas velocities up to 2000 km/s. Although the stratification of ions across the coronal region means that photoionization is the main power mechanism, the high velocities deduced from the profiles, the relatively large spatial extension of the emission, and the results from photoionization models indicate that an additional mechanism is at work. We suggest that shocks generated by the outflow could provide the additional required power for line formation.Comment: Accepted for publication in the Astrophysical Journal. 40 pages, 15 figures. Minor changes made on the affiliation of one co-autho

HLA-matched platelet transfusions are effective only in refractory patients with positive HLA antibody screening

BACKGROUND Recipients of platelet transfusions with 1-hour corrected count increments (1hCCIs) of 7.5 or less on two subsequent platelet transfusions with random platelets may benefit from human leukocyte antigen (HLA)-matched platelet concentrates. We aimed to quantify the efficacy of HLA-matched platelets concentrates expressed in 1hCCIs. METHODS We performed a cohort study among consecutive refractory patients who received HLA-matched platelet concentrates in the Netherlands between 1994 and 2017. We performed mixed-model linear regression comparing 1hCCIs after HLA split-antigen-matched transfusions with 1hCCIs after HLA-mismatched transfusions, adjusted for within-patient correlations. A donor-to-patient match was categorized as a split-match if all donor HLA-A and -B antigens were present in the patient as well; that is, donor and patient were HLA identical or compatible. Subgroup analyses were performed for patients with positive or negative HLA antibody screens. Finally, the additional effect of ABO mismatches on 1hCCIs was investigated. RESULTS The 1hCCI after an HLA-matched transfusion was 14.09 (95% reference interval, 1.13-29.89). This was 1.94 (95% confidence interval [CI], 0.74-3.15) higher than 1hCCI after HLA-mismatched transfusions. In patients with negative HLA antibody screening tests, HLA matching did not affect 1hCCIs. Conditional on HLA matching, 1hCCIs decreased by 3.70 (95% CI, -5.22 to -2.18) with major ABO mismatches. CONCLUSION Matched platelet concentrates yielded maximal 1hCCIs, whereas mismatched transfusions still resulted in adequate increments. There is no indication for HLA-matched platelets in patients with negative antibody screens